Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs Horizen (ZEN) Price & Performance

InjectiveTrade
HorizenTrade

Price performance (Past 24H)

Key statistics

Injective vs Horizen — how do they compare? Injective trades at Rp92,698 (market cap Rp9,29T, Rp1,78T 24h volume), while Horizen trades at Rp78,885 (market cap Rp2,29T, Rp96,68M 24h volume). The key difference: Injective is far larger — about 4.1× Horizen's market cap, and Horizen's supply is capped (15,1M / 21M ZEN (72%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Horizen for 80 Days on average.

INJZEN
Market Cap
Rp9,29TRp2,29T
Volume (24h)
Rp1,78TRp96,68M
Circulating Supply
100M INJ15,1M / 21M ZEN (72%)
Typical Hold Time
36 Days80 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Horizen

Horizen (ZEN) trades at Rp78,138 with a market cap of Rp2.29T, showing neutral technical signals overall. The asset maintains 72% circulating supply with bearish moving averages but neutral oscillators. Current price sits near resistance at R1 (Rp78,356) with support at S1 (Rp73,248). Recent ecosystem developments focus on privacy-focused blockchain solutions and sidechain scalability.

Outlook remains cautiously neutral with key resistance breakthrough potential. Major risks include typical crypto volatility and regulatory uncertainty. Opportunities exist if ZEN can demonstrate increased network utility and adoption in the privacy blockchain space amid growing institutional crypto interest.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
ZEN

No sentiment data available yet.

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About Horizen

Horizen (ZEN) is a zero-knowledge-enabled network of blockchains powered by the largest node infrastructure in the industry. Blockchain interoperability is enabled by the Zendoo protocol, which uses SNARK-verification and allows for complete flexibility in sidechain type, consensus, speed, and privacy.

Read more on ZEN